-
Drugs
-
Information on the Elimination of Chlorofluorocarbon-containing (CFC) Albuterol MDIs and Other Ozone-Depleting Drug Products
This web page provides links concerning the elimination of ozone-depleting substances from albuterol Metered-Dose Inhaler (MDI) medications and other communications regarding the removal of CFC-containing metered dose inhaler drugs from the U.S. market.
- Press Release (5/30/2008)
- Public Health Advisory (8/28/2008)
- Albuterol Questions & Answers (8/28/2008)
- Albuterol Consumer Article (5/30/2008)
- "Important Information For Users Of Albuterol CFC Inhalers" Public Service Announcement (8/28/2008)
- graphic image-PDF (low resolution, view version)
- graphic image-PDF (high resolution, print version)
- text-HTML
- Making the Switch -- Article for Pharmacists about Albuterol Transition (11/2008)
- Letter to Pharmacists about Albuterol Transition (8/29/2008)
- Letter to Schools about Albuterol Transition (6/23/2008)
- Availability of Albuterol Metered Dose Inhalers
- Metered Dose Inhalers: The Transition to Ozone-Safe Propellants (Environmental Protection Agency)
- Drug Treatments for Asthma and COPD that Do Not Use CFCs
- The Montreal Protocol on Substances that Deplete the Ozone Layer [external link]
- International Pharmaceutical Aerosol Consortium (IPAC). Provides links to resources that discusses upcoming changes to MDIs. [external link]
- Clean Air Act (Environmental Protection Agency)
Regulatory and Archived Documents
- Final Rule for Removal of Essential-Use Designation for CFC-containing Albuterol (April 2005)
- FDA Talk Paper on the Albuterol Final Rule (March 2005)
- Questions and Answers on Final Rule of Albuterol MDI's (March 2005)
- FDA Regulations Regarding the Use of Chlorofluorocarbons in Metered-Dose Inhalers (March 2005)
- "Your Metered-Dose Inhaler is Changing to Help Improve the Environment" Public Service Announcements (September 2003)
- One-page version:
- Two-page version:
Phase-out of epinephrine CFC metered-dose inhalers
-
-